<乌鸦传媒>No Survival Benefit With Immune Checkpoint Inhibitor Rechallenge in Metastatic RCC The strategy also led to increased toxicity Jun 06, 2023
<乌鸦传媒>New Data in NSCLC Bolster Support for Perioperative Immunotherapy EFS benefit with pembrolizumab in KEYNOTE-671, but no OS benefit "yet," says investigator Jun 05, 2023
<乌鸦传媒>Second-Line Axi-Cel Bests Standard in Relapsed/Refractory Large B-Cell Lymphoma The CAR T-cell therapy led to significantly longer overall survival Jun 05, 2023
<乌鸦传媒>New Agents for Relapsed/Refractory Myeloma Impress in Early-Stage Clinical Trials High rates of deep, durable response with bispecific antibody, rapidly produced CAR T-cell agents Jun 05, 2023
<乌鸦传媒>CAR-T Tops Standard Care in Heavily Pretreated Lenalidomide-Refractory Myeloma Ciltacabtagene autoleucel improved progression-free survival versus two standard triplets Jun 05, 2023
<乌鸦传媒>Omitting RT Safe in Many Locally Advanced Rectal Cancers Most intermediate-risk cases can be cured without pelvic radiation, says investigator Jun 05, 2023
<乌鸦传媒>Novel IDH1/2 Inhibitor Shows 'Dramatic Effect' in Low-Grade Glioma INDIGO data demonstrate that some patients can delay "toxic" chemo and radiation, says expert Jun 04, 2023
<乌鸦传媒>Nivolumab-AVD Boosts PFS in Untreated Hodgkin Lymphoma SWOG trial had goal of "harmonizing" treatment in adults, children with advanced-stage disease Jun 04, 2023
<乌鸦传媒>New Standard in Operable EGFR-Positive Lung Cancer "We should firmly close the door on one-size-fits-all treatment," says ASCO expert Jun 04, 2023
<乌鸦传媒>How a Medical Recoding May Limit Cancer Patients鈥� Options for Breast Reconstruction Many believe this would restrict women's options for surgery Jun 04, 2023
<乌鸦传媒>New Ovarian Cancer Drug Extends Survival in Resistant Disease "Practice changing" findings for tough-to-treat patient population Jun 04, 2023
<乌鸦传媒>Neoadjuvant Chemo Flops Versus Upfront Surgery for Resectable Pancreatic Cancer Survival 13 months better with surgery, but "curiosities" in neoadjuvant arm muddy the results Jun 04, 2023
<乌鸦传媒>Novel Anti-HER2 Drugs 'Impressive' in Advanced Biliary Cancer Response rates reached 41-47% with different approaches in rare disease Jun 03, 2023
<乌鸦传媒>Chemo-Free Approach Works in Subset of Patients With HER2+ Early Breast Cancer Impressive 3-year invasive DFS seen with adaptive response strategy using FDG-PET Jun 03, 2023
<乌鸦传媒>Pricey Drug Combo Boosts PFS in First-Line Advanced Ovarian Cancer Questions about anti-PD-L1 contribution, cost, and access to durvalumab, bevacizumab, olaparib Jun 03, 2023
<乌鸦传媒>De-Escalated Surgery Suffices for Low-Risk Cervical Cancer Simple hysterectomy non-inferior to radical operation Jun 02, 2023
<乌鸦传媒>CDK4/6 Extends Reach Into Early-Stage Breast Cancer Addition of ribociclib to endocrine therapy boosts disease-free survival in high-risk disease Jun 02, 2023
<乌鸦传媒>Adaptive RT Fails to Relieve Dry Mouth in Head and Neck Cancer "Expensive and intensive" process does not translate into clinical benefit, researchers conclude Jun 01, 2023
<乌鸦传媒>No Access to Routine Healthcare Biggest Barrier to HPV Vaccination Retrospective analysis shows vaccination rates haven't much improved for women since 2015 May 25, 2023
<乌鸦传媒>Medicaid Expansion Tied to Better Outcomes in Black Patients With GI Cancers Two-year mortality decreased for three types of GI cancer in expansion vs non-expansion states May 25, 2023
<乌鸦传媒>Less-Invasive Surgery for Pancreatic Cancer Proves Safe, Effective Radical resection rate noninferior to open surgery in early-stage disease, with similar survival May 25, 2023
<乌鸦传媒>Monoclonal Antibody Reduced Need For Transfusions in Low-Risk MDS Results suggest a "paradigm shift" in the treatment of anemia for these patients May 25, 2023
<乌鸦传媒>Cross-Border Collaboration Improves Survival in Pediatric Leukemia Patients 5-year OS increased to 100% in standard-risk ALL patients at a Tijuana hospital May 25, 2023
<乌鸦传媒>Trial Results Spark Talk of Curing More Metastatic Cervical Cancers Adding pembrolizumab to standard care extends overall survival by a year May 25, 2023
<乌鸦传媒>Lung Cancer Screening Results Influence Follow-Up Adherence Study suggests groups to target for enhanced outreach to encourage regular screening May 25, 2023
<乌鸦传媒>Warning: Prior Auth for Colonoscopy Is the Wrong Way to Go The policy adds delays to care and may worsen health outcomes May 24, 2023
<乌鸦传媒>What to Know About Hank Green's Hodgkin's Lymphoma Diagnosis Hodgkin's is one of the more rare lymphomas, but tends to be very treatable May 24, 2023
<乌鸦传媒>Anti-EGFR Rechallenge Boosts PFS in Third-Line Metastatic Colorectal Cancer ctDNA-identified wild-type tumors benefited most from adding panitumumab to standard therapy May 23, 2023
<乌鸦传媒>Lumpers vs Splitters: Categorizing Prostate Cancer Should very low-risk and low-risk be combined into one? May 19, 2023
<乌鸦传媒>Return of Rule Nixing Delivery of Rx Drugs to Medicare Patients Drawing Docs' Ire "It is endangering the lives of the oldest and sickest Americans," oncology group says May 18, 2023
<乌鸦传媒>ASCO Backs Routine ESR1 Testing for Certain Breast Cancers Activity of elacestrant in EMERALD trial "provides strong signal" for guideline update May 18, 2023
<乌鸦传媒>Survival Boost With Oncolytic Virus Combo in Glioblastoma Subset However, small trial failed to meet overall response endpoint in patients with recurrent disease May 16, 2023
<乌鸦传媒>Dermatologists Hone Diagnostic Accuracy for Suspect Lesions With AI 'Collaboration' Sensitivity, specificity, mean accuracy, and AUC improved significantly with neural network input May 16, 2023
<乌鸦传媒>Adding Mylotarg to Chemo Fails to Boost Survival in NPM1-Mutated AML But trial detects "meaningful benefit" when it comes to relapse, editorialists say May 15, 2023
<乌鸦传媒>Drug Shortages Hit Oncology; Telemedicine Tops In-Person; Sniffing Out Lung Cancer News, features, and commentary about cancer-related issues May 12, 2023
<乌鸦传媒>CDC: Drug-Resistant Ringworm in U.S.; Mail-In HPV Tests Work; Pope Urges Procreation Health news and commentary from around the Web gathered by 乌鸦传媒 staff May 12, 2023
<乌鸦传媒>Allo-Transplant Tied to Better PFS in Advanced Cutaneous T-Cell Lymphomas Results will likely "encourage a practice change," editorialists say May 10, 2023
<乌鸦传媒>FLT3 Inhibitor Doubles Overall Survival in Acute Myeloid Leukemia Median OS improved from 15 months to nearly 32 months with quizartinib May 09, 2023
<乌鸦传媒>AI in Colonoscopy: Disconnect Grows Between Academic, Community Studies Clearly helpful in manufacturers' trials, but not so much in routine practice May 09, 2023
<乌鸦传媒>Proposed Breast Cancer Screening Guidelines Are Good, but Not Enough Specifics for older women, Black women, and those with dense breasts are needed May 09, 2023
